Connecticut ACA Marketplace Faces Significant Federal Subsidy Cuts by 2026
Connecticut's ACA marketplace will face significant subsidy cuts by 2026, impacting 150,000 residents and programs like Covered Connecticut amid federal regulatory changes.
Connecticut's ACA marketplace will face significant subsidy cuts by 2026, impacting 150,000 residents and programs like Covered Connecticut amid federal regulatory changes.
Analysis of Ohio hospitals' financial outlook under the One Big Beautiful Bill Act reveals temporary rural hospital funding amid deeper Medicaid cuts, increasing uninsured numbers and operational risks.
HRRMC Board discusses financial impacts of OBBBA Medicaid funding cuts, adoption of CORA policy, and rural hospital funding outlook under new federal regulations.
KFF’s July 2025 poll highlights deep partisan divides in public opinion on the new U.S. tax and budget bill impacting Medicaid and ACA health programs, revealing varied perceptions among insurance stakeholders and social media effects.
New federal Medicaid cuts and funding caps pose challenges for rural hospitals, risking closures and reduced healthcare access. Analysis covers impacts, provisions, and rural healthcare responses.
Medicaid funding cuts and new work verification rules under 2023 tax legislation risk coverage loss for millions, complicate state programs, and shift costs to states.
CMS introduces WISeR model using AI to expedite Medicare prior authorizations while insurers enhance processes to cut waste and improve care approval speeds.
Explore how federal Medicaid cuts under H.R.1 threaten rural hospitals like Petaluma Valley Hospital, impacting healthcare access, funding, and insurance reimbursement dynamics. Understand evolving challenges in hospital sustainability and workforce shortages.
Explore the impact of federal Medicaid spending cuts on Georgia's Medicaid coverage gap, disability waiver programs, and rural healthcare providers. Learn about Pathways to Coverage limitations and policy implications.
Prescription drug denials by private insurers rise 25% (2016-2023). Sarepta gene therapy linked to patient deaths. ICE gains Medicaid data access. ACA insurers seek 2026 rate hikes. Implications for U.S. insurance, regulatory compliance, and patient access.